SCHEMBL19150296

SCHEMBL19150296

S=C(S)c1cc[nH]n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1273778 0.80
SCHEMBL4961404 0.78
SCHEMBL3259733 0.76
SCHEMBL7561905 0.76
SCHEMBL4961396 0.76
SCHEMBL6208530 0.76
Hydrochloric Acid SCHEMBL5591159 0.74
SCHEMBL28914335 0.74
SCHEMBL1273234 0.70
SCHEMBL22616190 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118406090-A Neutral triisocomplex iridium complex containing dithioformic acid derivative coordination, and preparation method and application thereof 深圳信息职业技术学院 2024-07-30 CN disclosed
US-20200405881-A1 CELL BASED METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENT DELIVERY AND TREATMENTS USING SAME UNIVERSITY OF WASHINGTON (US) 2020-12-31 US disclosed
US-20200276318-A1 ENGINEERED CELLS AND AGENT COMPOSITIONS FOR THERAPEUTIC AGENT DELIVERY AND TREATMENTS USING SAME UNIVERSITY OF WASHINGTON (US) 2020-09-03 US disclosed
WO-2018165198-A1 CELL-BASED METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENT DELIVERY AND TREATMENTS USING SAME UNIVERSITY OF WASHINGTON (US) 2018-09-13 WO disclosed
WO-2018165194-A1 ENGINEERED CELLS AND AGENT COMPOSITIONS FOR THERAPEUTIC AGENT DELIVERY AND TREATMENTS USING SAME UNIVERSITY OF WASHINGTON (US) 2018-09-13 WO disclosed
WO-2017124139-A1 PROCESS FOR INHIBITING HYDRATE FORMATION IN HYDROCARBON PRODUCTION COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2017-07-27 WO disclosed